3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases

Autor: Jansen, Y., Corthals, J., Wilgenhof, S., Schreuer, M., Heirman, C., Thielemans, K., Neyns, B.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S673-S673
Databáze: ScienceDirect
Externí odkaz: